Brought to you by 
Home Diagnostics nets $48.7mm with IPO
12 Oct 2007
Executive Summary
Home Diagnostics Inc. (HDI), a company that specializes in diabetes management, netted $48.7mm in its initial public offering of 4.3mm common shares (including the overallotment) at $12 apiece. In May, it originally hoped to sell up to $115mm, and in July it changed the estimate to 3.3mm shares at $14-16. Shareholders also sold some of their stock in the IPO.
Deal Industry
- In Vitro Diagnostics
-
Medical Devices
- Monitoring Equipment & Devices
-
In Vitro Diagnostics
- Biosensors
- Glucose Testing
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Home Diagnostics nets $48.7mm with IPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice